Skip to Main Content

Paper Details

Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
Leuk Res
9
2018
-ITD, -KITwt, AML, AMLs, APL, CBF, CBF-, CBF-KITwt, CEBPA, CEBPAmut, CEBPAmut/mut, CEBPAmut/mut AML, FLT3-ITD, KIT, KITwt, NPM1, NPM1mut, NPM1mut AML, Patients, acute myeloid leukemia, acute promyelocytic leukemia, core-binding factor, core-binding factor (CBF) rearrangements, inv(16, leukemias, patients, t(16;16), t(8;21), transcription-related genes
Author NameAffiliation
Paul Brent FerrellVanderbilt University School of Medicine, United States Vanderbilt Ingram Cancer Center
Paul Brent FerrellVanderbilt University School of Medicine, United States Vanderbilt Ingram Cancer Center
Thomas StrickerVanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine
Cindy L Vnencak-JonesVanderbilt University School of Medicine
  • 1 - 4

Datasets

Release 1.2